Key Insights

Highlights

Success Rate

84% trial completion

Published Results

20 trials with published results (10%)

Research Maturity

56 completed trials (29% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.6%

11 terminated out of 196 trials

Success Rate

83.6%

-3.0% vs benchmark

Late-Stage Pipeline

14%

28 trials in Phase 3/4

Results Transparency

36%

20 of 56 completed with results

Key Signals

20 with results84% success11 terminated

Data Visualizations

Phase Distribution

133Total
Not Applicable (44)
Early P 1 (5)
P 1 (29)
P 2 (27)
P 3 (10)
P 4 (18)

Trial Status

Recruiting73
Completed56
Not Yet Recruiting42
Terminated11
Unknown5
Active Not Recruiting4

Trial Success Rate

83.6%

Benchmark: 86.6%

Based on 56 completed trials

Clinical Trials (196)

Showing 20 of 20 trials
NCT07761767Not ApplicableNot Yet RecruitingPrimary

Self-Care Education for Joint Stiffness and Functional Ability in Rheumatoid Arthritis

NCT07760662RecruitingPrimary

Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid Arthritis

NCT07754552Not ApplicableNot Yet Recruiting

Development and Evaluation of the Effectiveness of the SMART-HAND Protocol for Hand Rehabilitation in Patients With Rheumatoid Arthritis

NCT07564154Phase 1RecruitingPrimary

A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)

NCT07245992Phase 1RecruitingPrimary

A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis

NCT02541955Phase 4CompletedPrimary

Use of Acthar in Rheumatoid Arthritis (RA) Related Flares

NCT06687551Phase 4RecruitingPrimary

JAK Inhibitor Dose TAPering Strategy Study

NCT07748728Phase 2Not Yet RecruitingPrimary

TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs

NCT07745426Phase 2RecruitingPrimary

Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis

NCT03840785Not ApplicableCompletedPrimary

Inflammatory Arthritis and Tango

NCT06991114Phase 2Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT07740200CompletedPrimary

Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional, Non-Academic Study

NCT07737119Not ApplicableCompletedPrimary

Impact of Optimised Protein Intake on Household Work Limitations and Disability in Rheumatoid Arthritis

NCT07729995Phase 1Not Yet RecruitingPrimary

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease

NCT07730723Phase 2Not Yet RecruitingPrimary

The Effect of Nicorandil on Rheumatoid Arthritis Patients

NCT06706999Not ApplicableCompletedPrimary

Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)

NCT07721142Phase 4RecruitingPrimary

Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis

NCT07484243RecruitingPrimary

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

NCT07401732RecruitingPrimary

Dysphagia in Rheumatoid Arthritis

NCT03631225CompletedPrimary

The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

Scroll to load more

Research Network

Activity Timeline